Impact of multifactor intensive intervention on self management, risk factor control and outcome of post percutaneous transluminal coronary intervention patients

Chinese Journal of Cardiology

Volumn 40, Issue 12, 2012, Pages 1037-1040

  He, Ya Ping ^a   Lu, Zhi Gang ^a   Gu, Yong Wen ^a   Pan, Jing Wei ^a   Gao, Mei Fang ^a   Wei, Meng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Angioplasty, transluminal, percutaneous coronary; Coronary disease; Intervention studies

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIETARY INTAKE; EXERCISE; FOLLOW UP; HUMAN; INTENSIVE CARE; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MULTIFACTOR INTENSIVE INTERVENTION; OUTPATIENT; RISK MANAGEMENT; SELF CARE; TELEPHONE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT DURATION;

AGED; CAUSALITY; CORONARY DISEASE; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84872166324     PISSN: 02533758     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3758.2012.12.012     Document Type: Article

References (8)

1. Bi Y, Gao R, Patel A, et al. Evidence-based medication at the time of hospital discharge and 1 year after hospitalization: Results from the Clinical Pathway for acute coronary syndromes in China (CPACS) study. Am Heart J, 2009, 157: 509-516.
2. 2007, 35: 420-427.
3. Smith S C Jr, Allen J, Blair S N, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation, 2006, 113: 2363-2372.
4. Fernandez R S, Griffiths R, Juergens C, et al. Persistence of coronary risk factor status in participants 12 to 18 months alter percutaneous coronary intervention. J Cardiovasc Nurs, 2006, 21: 379-387.
5. Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet, 2009, 373: 929-940.
6. 2011, 38: 122-125.
7. 2007, 21: 800.
8. Wood D A, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTTON) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet, 2008, 371: 1999-2012.